Hepatitis C – Prävalenz, Bedeutung und Implikationen für die Prävention und Gesundheitsförderung
Authors:
- 20 March 2020
- book chapter
- Published by Springer Nature
- p. 1-8
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Direct-Acting Antiviral Agents for Patients With Hepatitis C Virus Genotype 1 Infection Are Cost-SavingClinical Gastroenterology and Hepatology, 2017
- Changes in the Prevalence of Hepatitis C Virus Infection, Nonalcoholic Steatohepatitis, and Alcoholic Liver Disease Among Patients With Cirrhosis or Liver Failure on the Waitlist for Liver TransplantationGastroenterology, 2017
- Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling studyThe Lancet Gastroenterology & Hepatology, 2017
- Real‐world use, effectiveness and safety of anti‐viral treatment in chronic hepatitis C genotype 3 infectionAlimentary Pharmacology & Therapeutics, 2017
- Global epidemiology and burden of HCV infection and HCV-related diseaseNature Reviews Gastroenterology & Hepatology, 2016
- Reduction in liver transplant wait‐listing in the era of direct‐acting antiviral therapyHepatology, 2016
- HCV epidemiology in high-risk groups and the risk of reinfectionJournal of Hepatology, 2016
- Die Seroepidemiologie der Hepatitis A, B und C in DeutschlandBundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz, 2013
- Natural history of acute and chronic hepatitis CBest Practice & Research Clinical Gastroenterology, 2012
- Expertenempfehlungen zur Triple-Therapie der HCV-Infektion mit Boceprevir und TelaprevirZeitschrift für Gastroenterologie, 2012